| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/11/2003 | WO2003032912A3 Treatment of cns disorders using cns target modulators |
| 12/11/2003 | WO2003017940A3 Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 12/11/2003 | WO2003011226A3 Products and drug delivery vehicles |
| 12/11/2003 | WO2003003975A3 Detection and therapy of vulnerable plaque with photodynamic compounds |
| 12/11/2003 | WO2003000241A3 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents, for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 12/11/2003 | WO2003000179A3 Chemically-modified progenipoietin conjugates |
| 12/11/2003 | WO2002089853A3 Compositions having enhanced pharmacokinetic characteristics |
| 12/11/2003 | WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 12/11/2003 | WO2002087498A8 Diagnostic imaging compositions, their methods of synthesis and use |
| 12/11/2003 | WO2002080883A3 Method and composition for solubilising a biologically active compound with low water solubility |
| 12/11/2003 | WO2002078648A3 Topical composition comprising an antifungal |
| 12/11/2003 | WO2002077034A3 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 12/11/2003 | WO2002065943A3 Ocular tear growth factor-like protein |
| 12/11/2003 | WO2002008174A8 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 12/11/2003 | US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors |
| 12/11/2003 | US20030229390 On-stent delivery of pyrimidines and purine analogs |
| 12/11/2003 | US20030229202 Comprises fusion protein for intracelluar delivery of compounds of interest into cells; drug delivery |
| 12/11/2003 | US20030229140 Plant extracts; chlorogenic acid |
| 12/11/2003 | US20030229111 Naltrexone hydrochloride compositions |
| 12/11/2003 | US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance |
| 12/11/2003 | US20030229056 Composition for aqueous stabilization of fat-soluble vitamins |
| 12/11/2003 | US20030229052 Aqueous ifosfamide composition |
| 12/11/2003 | US20030229049 Injectable mixture of chondrosamine sulfate, glucosamine hydrochloride, dimethyl sulfoxide and dextrose with anesthetic |
| 12/11/2003 | US20030229047 Liquid formulation of decitabine and use of the same |
| 12/11/2003 | US20030229034 Drug delivery; nucleic acids; complexing |
| 12/11/2003 | US20030229028 Complexing drug with spacer and galactose |
| 12/11/2003 | US20030229022 Sustained release; angigenesis inhibitors |
| 12/11/2003 | US20030229010 Antidiabetic agents; water in oil microemulsion; immobilization |
| 12/11/2003 | US20030229009 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 12/11/2003 | US20030229006 Amphiphilic oligomers |
| 12/11/2003 | US20030228652 Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| 12/11/2003 | US20030228644 Pro drugs for selective drug delivery |
| 12/11/2003 | US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents |
| 12/11/2003 | US20030228382 Foot Fixer Kit |
| 12/11/2003 | US20030228378 Water-soluble stable salts of petroselinic acid |
| 12/11/2003 | US20030228376 Novel topical microbicidal compositions |
| 12/11/2003 | US20030228366 Uniformity stable colloid solution |
| 12/11/2003 | US20030228365 Pharmaceutical formulation |
| 12/11/2003 | US20030228362 Controlled release lipoic acid |
| 12/11/2003 | US20030228359 Antiallergen mixture |
| 12/11/2003 | US20030228358 Mixture containing low solubility drug and polymer |
| 12/11/2003 | US20030228357 Sizing, compaction, forming tablets |
| 12/11/2003 | US20030228355 Precipitation of lipid; fineness particle size |
| 12/11/2003 | US20030228354 Drug in pressure sensitive adhesive |
| 12/11/2003 | US20030228353 Wound heraling agents; polypeptide |
| 12/11/2003 | US20030228335 Prevention, therapy of skin disorders; mixture of halogenated hydrocarbon and anhydrous lipid |
| 12/11/2003 | US20030228319 Antitumor agents, anticancer agents |
| 12/11/2003 | US20030228318 PSCA: prostate stem cell antigen and uses thereof |
| 12/11/2003 | US20030228305 Compositions and methods for the diagnosis and treatment of tumor |
| 12/11/2003 | US20030228275 Immobilization of drugs |
| 12/11/2003 | US20030228273 Novel high viscosity embolizing compositions comprising prepolymers |
| 12/11/2003 | US20030228260 Drug delivery; central nervous system disorders |
| 12/11/2003 | US20030228258 Suicide tetramers and uses thereof |
| 12/11/2003 | US20030228257 Induction apoptosis; antiarthritic agents |
| 12/11/2003 | US20030228254 Contrast agents |
| 12/11/2003 | US20030228253 Radiolabelled thioplatin, compositions thereof and methods of cancer treatment |
| 12/11/2003 | CA2488287A1 Use of a synergistic combination of chlorogenic acid and 3-o-p-coumaryl quinic acid as an anti-leukemic therapy |
| 12/11/2003 | CA2488269A1 Methods and compositions for intravesical therapy of bladder cancer |
| 12/11/2003 | CA2488251A1 Novel solid preparation containing block copolymer and anthracycline anticancer agent and process for producing the same |
| 12/11/2003 | CA2487926A1 Suicide tetramers comprising mhc class i and uses thereof |
| 12/11/2003 | CA2487882A1 Transmucosal delivery of cannabinoids |
| 12/11/2003 | CA2487815A1 Targeted therapeutic proteins |
| 12/11/2003 | CA2487786A1 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone |
| 12/11/2003 | CA2487757A1 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 12/11/2003 | CA2487720A1 Therapeutic agent-containing polymeric nanoarticles |
| 12/11/2003 | CA2487692A1 Methods and compositions for radioimmunotherapy of brain and cns tumors |
| 12/11/2003 | CA2487639A1 Self-administered contraceptive injection of oily solution |
| 12/11/2003 | CA2487585A1 Formulations for amylin agonist peptides |
| 12/11/2003 | CA2487305A1 Topical drug delivery using phosphatidylcholine |
| 12/11/2003 | CA2487304A1 Materials and methods relating to polyions and substance delivery |
| 12/11/2003 | CA2487171A1 Method for the protection of endothelial and epithelial cells during chemotherapy |
| 12/11/2003 | CA2486676A1 Polyol-modified silanes as precursors for silica |
| 12/11/2003 | CA2486424A1 Oil-soluble pigment compositions |
| 12/11/2003 | CA2485932A1 Pharmaceutical composition containing oxcarbazepine and having a controlled active substance release |
| 12/11/2003 | CA2485533A1 Immediate release pharmaceutical formulation |
| 12/11/2003 | CA2485080A1 Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof |
| 12/11/2003 | CA2484626A1 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b |
| 12/11/2003 | CA2483834A1 Norethindrone sustained release formulations and methods associated therewith |
| 12/10/2003 | EP1369432A2 Soluble highly branched glucose polymers and process for their preparation |
| 12/10/2003 | EP1369429A1 GCSF conjugates |
| 12/10/2003 | EP1369133A1 Gene carriers with the use of polysaccharide and process for producing the same |
| 12/10/2003 | EP1369132A1 Oxaliplatin containing liposome preparation |
| 12/10/2003 | EP1369130A1 Process for producing sustained release preparation |
| 12/10/2003 | EP1369128A1 Inhibitors of glycoprotein VI and their therapeutic use |
| 12/10/2003 | EP1369112A1 Percutaneous absorption-type pharmaceutical preparation and process for producing the same |
| 12/10/2003 | EP1369110A1 Production of nanoparticles from methyl vinyl ether copolymer and maleic anhydride for the administration of hydrophilic pharmaceuticals, more particularly of puric and pyrimidinic bases |
| 12/10/2003 | EP1369108A1 Composition for use in electroporation |
| 12/10/2003 | EP1369106A1 Emulsion composition |
| 12/10/2003 | EP1368486A2 Formulations for il-11 |
| 12/10/2003 | EP1368419A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge |
| 12/10/2003 | EP1368371A2 Transfection complexes |
| 12/10/2003 | EP1368318A2 Calcilytic compounds |
| 12/10/2003 | EP1368253A1 Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein |
| 12/10/2003 | EP1368063A2 Complex of modafinil and cyclodextrin |
| 12/10/2003 | EP1368062A2 Composition and method |
| 12/10/2003 | EP1368057A2 Method to enhance the immunogenicity of an antigen |
| 12/10/2003 | EP1368056A1 Recombinant gelatin-like proteins for use as plasma expanders |
| 12/10/2003 | EP1368054A2 Using neural thread proteins to treat tumors and other hyperproliferative disorders |
| 12/10/2003 | EP1368053A2 Compositions and methods for treating gonadotrophin related illnesses |
| 12/10/2003 | EP1368048A1 Pharmaceutical composition made of cannabis extracts |